BioProject,Run,EV_type,Source,disease,Disease_stage/treatment,Release_date,URL,EV isolated method,Project_Title,Project_Description
PRJNA951775,SRR24055586,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055587,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055588,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055589,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055590,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055591,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055592,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055593,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055594,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055595,sEV,Blood,Schizophrenia,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055596,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055597,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055598,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055599,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055600,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055601,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055602,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055603,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055604,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
PRJNA951775,SRR24055605,sEV,Blood,Healthy donor,-,2023-10-09,https://pubmed.ncbi.nlm.nih.gov/37605121/,About 5 ml of plasma was isolated from 10 ml of peripheral blood. The plasma exosome was extracted from 5 ml plasma of participants. The exosomes were isolated using the exoEasy Maxi Kit (Qiagen) following the manufacturer’s protocol.,Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia (human),"This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.
Overall design: we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the miRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the lncRNA expression level of plasma exosome by high throughput sequencing
we recruited 10 FOS patients and healthy controls (HCs) respectively, examined the mRNA expression level of plasma exosome by high throughput sequencing"
